Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-07-000784
Filing Date
2007-03-15
Accepted
2007-03-15 12:14:29
Documents
3
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER cmw2747.htm 6-K 679348
2 GRAPHIC kpmg.gif GRAPHIC 1723
3 COMMON STOCK PRIVATE PURCHASE AGREEMENT cmw2747a.htm EX-10 115774
  Complete submission text file 0000897069-07-000784.txt   799083
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 07695665
SIC: 2835 In Vitro & In Vivo Diagnostic Substances